## **Core Concept**
Pediatric acute lymphoblastic leukemia (ALL) is a type of cancer that affects the blood and bone marrow in children. Prognostic factors help predict the likelihood of disease remission and long-term survival. These factors guide treatment decisions.

## **Why the Correct Answer is Right**
The correct answer, , is associated with a poorer prognosis in pediatric ALL. This is because certain genetic abnormalities, such as the MLL gene rearrangement (t(4;11)), are linked to a worse outcome. Other good prognostic factors include age between 1-10 years, low white blood cell count at diagnosis, and specific genetic markers like the TEL-AML1 fusion.

## **Why Each Wrong Option is Incorrect**
* **Option A:** is a good prognostic factor because it is associated with a favorable outcome in pediatric ALL.
* **Option B:** is also a good prognostic factor, as it indicates a more responsive disease to chemotherapy.
* **Option C:** represents a good prognostic factor, as an age between 1-10 years is associated with better survival rates.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the presence of certain genetic abnormalities, such as the BCR-ABL fusion or MLL gene rearrangement, significantly impacts the prognosis and treatment plan for pediatric ALL. Understanding these genetic markers is crucial for risk stratification.

## **Correct Answer:** .